
Collaboration in Biopharma
pharmafile | October 27, 2017 | Feature | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â biotech, drugs, pharma, pharmaceuticalÂ
Dear Colleague,
Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological challenges – but what makes the most effective collaborative process? We invite you to participate in this short industry-wide survey which seeks to analyse the quality of collaborative processes in the biopharmaceutical industry.
The survey is available here until Wednesday 8 November and, in return, a £5 donation will be made to charity for each completed survey (up to a maximum of £1,000).
Thank you for your time and consideration.
On behalf of CHASE
Related Content

Pharma sees climate disruption as growing supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech
Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed …





